Pharmaceuticals, Biotech & Life Sciences Brands · Advertiser / Brand
Bayer
Diversified life sciences company spanning pharmaceuticals, consumer health and agriculture.
Available information varies by company and source.
Profile record updated:
Company facts
- Official name
- Bayer AG
- Entity type
- COMPANY
- Founded
- 1863
- Headquarters
- Germany
- Company size
- >5,000
- Market cluster / sector
- Pharmaceuticals, Biotech & Life Sciences Brands
- Market role
- Advertiser / Brand
- Ticker
- BAYN
- Official website
- bayer.com
What Bayer does
Bayer creates value by researching, manufacturing, commercialising and distributing life sciences products across healthcare and agriculture. Its business model is built around product innovation, regulatory approvals, branded portfolios, large-scale manufacturing, channel distribution and recurring demand for medicines, health products and crop-related inputs.
Category differentiation
This is the German life sciences group, not an adtech, martech or media company. It should not be confused with a software platform, agency or publisher brand.
Strategic context
AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.
Bayer is a diversified life sciences company best known for operating across prescription medicines, consumer health products and agricultural inputs. It generates revenue primarily from selling branded and portfolio-based products through healthcare, pharmacy, retail and agricultural channels rather than from advertising, media, software or agency services. Its customers span healthcare providers, wholesalers, pharmacies, retailers, farmers and agricultural distribution partners, with some products ultimately reaching consumers. Based on the limited input provided, Bayer should be understood as a large operating company in healthcare and agriculture rather than a martech, adtech, publishing or SaaS business.
Company news briefing
Briefing updated:
Bayer is advancing its seed and crop protection pipeline alongside blockbuster launches, complemented by a commercial agreement with Neste to scale newgold winter canola for biofuels, and US regulatory clearance for its Xarelto successor. In digital strategy, the Consumer Health brand Iberogast successfully shifted TV budgets to YouTube Connected TV to boost reach, while executives highlighted inconsistent measurement standards as a barrier to retail media investment. Additionally, Bayer has been enlisted as a data provider for Amazon's planned global product database.
Business model & monetisation
The company monetises through direct product sales, channel sales and wholesale distribution across regulated life sciences markets. Revenue is typically driven by product volume, brand strength, patent- or formulation-based differentiation, and repeat purchasing through healthcare and agricultural supply chains rather than SaaS subscriptions or media monetisation.
Products & capabilities
No products with linked sources are available in this view.
POLARIS7 WORKSPACE
Go deeper on Bayer and its market context
Access extended corporate structures, historical M&A and partnership links, technical footprint data, and automated Watchlist briefings grounded in primary sources.
- Corporate & subsidiary hierarchy
- Competitor & partner network
- Automated Watchlist briefings
Competitors & alternatives
Track competitor shifts
Receive automated telemetry on strategic moves, acquisitions, and market share shifts across Bayer's competitive landscape.
Global pharmaceutical company selling medicines and vaccines.
Large public healthcare manufacturer and commercial products company.
Public crop science company selling seeds and farm inputs.
Biopharmaceutical company developing and commercialising prescription medicines.
Consumer goods group selling health, hygiene and nutrition brands.
Side-by-side comparisons
Recent recorded signals
Dates refer to the source publication. Older entries are historical context, not evidence of a new event.
Infineon rally lifts DAX, oil price supports
Financials · Recorded impact score: 2/5
German stock markets rose on Tuesday, with the DAX climbing 1.1% to 26,543 points, approaching its record high, supported by falling oil prices and strong earnings from Infineon. Infineon, which expects accelerated growth in fiscal 2026/27 due to strong demand for power chips for AI data centers, saw its shares jump 5.8%. Henkel confirmed its annual targets, and its shares rose 2.0%. K+S sharpened its profit outlook but its shares fell 2.5%. Bayer was allowed to sell its Xarelto successor in the US, lifting shares by 1%. US markets also rallied, with the Dow up 2.15%, S&P 500 up 2.35%, and Nasdaq 100 up 3.40%, driven by lower oil prices. Brent crude fell 1.5% to $91.17, WTI 1.6% to $85.48, after President Trump said a US strike on Iran was not necessary at this time.
- DAX rose 1.1% to 26,543 points.
- Infineon expects accelerated growth in fiscal 2026/27, shares +5.8%.
Streuplan Creates Three TV Spots for Bayer Switzerland
Campaign · Recorded impact score: 1/5
The Swiss agency Streuplan has developed a summer campaign for Bayer Schweiz to promote Bepanthen MED Plus. The campaign's centerpiece is three TV spots depicting a hiking family encountering minor mishaps, which alter their planned excursion. Each spot addresses a different everyday situation: differing parenting views, excessive smartphone use, and a runaway cheese disrupting a photo session. The films aired on TV channels across German-speaking Switzerland, French-speaking Switzerland, and Ticino, targeting relevant audiences. The production was shot over two days in Morschach, Switzerland, with Salient Media handling production and Nicholas Beyeler directing. Both long and short TV versions were created, along with adaptations for social media in landscape and portrait formats. A key visual for point-of-sale communications was also produced. The campaign ran during the summer across all three language regions.
- Streuplan created a summer campaign for Bayer Schweiz promoting Bepanthen MED Plus.
- The campaign consists of three TV spots showing a hiking family experiencing minor mishaps.
German Companies Cut Thousands of Management Jobs
Corporate Restructuring · Recorded impact score: 1/5
German corporations are eliminating thousands of management positions, particularly in the middle management layer between C-suite and operational business. Volkswagen plans to cut about 5,000 of its 21,500 management roles worldwide, BMW is reducing leadership levels, and BASF has already shed 11% of its managers in the past two years. In 2025, a record 49,000 executives were unemployed. Bayer CEO Bill Anderson is spearheading a radical restructuring, aiming to eliminate up to 12,000 of roughly 17,000 leadership positions by flattening the corporate hierarchy from twelve levels. This trend is driven by weak economic conditions, high transformation costs, and a desire for leaner, faster organizations. Affected managers face not only financial uncertainty but also loss of status and identity, and re-entering the job market is challenging as companies now prioritize operational experience, technology skills, and change management capability.
- Volkswagen plans to cut approximately 5,000 of its 21,500 management positions worldwide.
- BASF has reduced its leadership workforce by 11% over the past two years.
Iberogast's Big Screen YouTube Strategy Boosts Reach by 17 Points
CTV, Media Planning · Recorded impact score: 3/5
At the YouTube Festival 2026, Bayer's Consumer Health brand Iberogast presented a case study on shifting TV budget to YouTube to reach younger audiences. Facing an awareness gap among 25-44 year-olds, Bayer used Google's DV360 Reach Planner to model an integrated cross-media plan. The recommendation was to shift 30% of the TV budget to YouTube, targeting Connected TV (Big Screen) with non-skippable ads. The campaign achieved a net reach of 67%, 17 percentage points higher than a pure TV campaign, exactly as predicted. Brand Lift data showed a 41% increase in ad recall and a 7% increase in purchase intent. This pilot has become the new standard for Bayer Consumer Health, which now orchestrates a holistic Big Screen strategy across its brand portfolio, planning linear TV and YouTube together.
- Bayer shifted 30% of Iberogast's TV budget to YouTube as recommended by Google's DV360 Reach Planner.
- The campaign reached 67% net reach in target audience, 17 percentage points higher than a TV-only campaign.
YouTube Festival 2026: Brands See 90% More ROI Than TV
Platform · Recorded impact score: 2/5
At the YouTube Festival 2026 in Berlin, Google executives and brand marketers highlighted YouTube's growing importance in media planning. Philipp Justus, Google's VP Central Europe, emphasized YouTube's cultural influence, while Marianne Stroehmann presented data showing 90% more ROI compared to TV. Case studies from E.ON and Nestlé demonstrated successful creator collaborations and the effectiveness of YouTube in driving brand consideration and conversions. Bayer's media planning with Display & Video 360 increased reach from 45% to 67%. The event underscored a paradigm shift from traditional TV advertising to creator-driven, culturally embedded content on YouTube.
- Google's YouTube Festival 2026 took place in Berlin on September 17, 2026.
- YouTube reportedly delivers 90% more ROI than TV according to Google.
Explore company relationships
Questions about Bayer
What is Bayer?
Bayer is a diversified life sciences company operating in pharmaceuticals, consumer health and agricultural products.
Who uses Bayer?
Its products are bought or prescribed through healthcare providers, pharmacies, retailers, farmers and agricultural distribution channels, with some products ultimately used by consumers.
How does Bayer make money?
It makes money primarily by selling medicines, health products and agricultural inputs through regulated commercial channels and distribution networks.
Sources & coverage
This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.
5 publicly documented primary sources and citations linked across the market graph.
Start with a company or market. Track what changes.
Create your Polaris7 workspace to explore extended company profiles, organize relevant players into Watchlists, and receive focused briefings when material changes occur.
Bayer
Open extended company details, ownership links, and automated signal monitoring in Polaris7.
